![Surviving-an-FDA-GCP-Inspection-500.jpg Surviving an FDA GCP Inspection](https://www.centerwatch.com/ext/resources/products/Surviving-an-FDA-GCP-Inspection-500.jpg?height=200&t=1605810958&width=200)
Home » Covance Expands Presence in Ukraine, Slovakia and Israel
Covance Expands Presence in Ukraine, Slovakia and Israel
February 4, 2009
Covance opened three new clinical development offices in Central and Eastern Europe and the Middle East to speed clinical trials and develop strategic relationships in those areas.
Covance has been providing services in Central and Eastern Europe since 1994 and in Israel since 1995.
The new offices are located in Kiev, Ukraine; Bratislava, Slovakia; and Tel Aviv, Israel. The Kiev and Bratislava offices will support staff and the CRO’s regional network of field-based clinical research associates (CRAs). The Israel office will serve as the center of operations for Covance’s staff in Greece and Turkey and the Middle East (Israel and Egypt).
"We will continue moving forward with our strategy to expand into geographies that align our therapeutic focus with investigators that consistently demonstrate high-quality results, regulatory compliance, and enrollment performance to meet the current and future clinical research needs of our clients,” said Robert Davie, Ph.D., vice president and general manager, clinical development services Europe, Covance, in a company statement.
Upcoming Events
-
21Oct